Evertas

Evertas is a transdermal patch containing rivastigmine, used to manage symptoms of Alzheimer's and Parkinson's disease. This medication helps improve cognitive function and daily living activities.

Evertas is primarily used for the treatment of mild to moderate dementia associated with Alzheimer's and Parkinson's disease. Rivastigmine, the active ingredient, works by increasing certain chemicals in the brain that are involved in cognitive processes. This patch is designed for transdermal use, providing a steady release of the medication through the skin.

Common effects of Evertas may include skin irritation at the application site, nausea, vomiting, and dizziness. Some users may also experience headaches or loss of appetite. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Evertas should be used with caution in individuals with a history of skin conditions or allergies. It is important to apply the patch to clean, dry skin and rotate application sites to minimize skin irritation. Avoid exposing the patch to high temperatures or direct sunlight, as this can affect its effectiveness.

Evertas may interact with other medications, including those that affect the central nervous system. Alcohol and certain over-the-counter drugs may also interact with rivastigmine. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.